Tranylcypromine

Commodity a leaf — nothing below it, 8 links to KBLI

Level: Commodity
Parent: 51292000
Below: 0
Links · KBLI: 8

Definition

UNSPSC 51292018

This classification denotes a monoamine oxidase inhibitor with the molecular formula C9H11N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3E3V44J4Z9, chemically known as cyclopropylamine, trans-2-phenyl- but generally known as tranylcypromine, which bears US NIH Compound Identifier 5530. European Medicines Agency schedules Tranylcypromine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11218MIG. The term TRANYLCYPROMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules tranylcypromine in its Anatomical Therapeutic Chemical (ATC) Classification. TRANYLCYPROMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tranylcypromine under HS 29214980 and SITC 51454. As of Q4 2014, TRANYLCYPROMINE remains the US FDA Preferred Term for this commodity. Tranylcypromine bears US NLM identifiers UMLS ID C0040778 and NCI Concept Code C61979. SMILES: NC1C(C1)c1ccccc1.

Same parent

Under 51292000 · 29

51292001 Adrafinil Commodity 51292002 Amiflamine Commodity 51292003 Ansoxetine Commodity 51292004 Citalopram Commodity 51292005 Clorgiline Commodity 51292006 Dapoxetine Commodity 51292007 Melitracen Commodity 51292008 Diisopromine or disoprominum Commodity 51292009 Escitalopram Commodity 51292010 Flunamine Commodity 51292011 Fluoxetine Commodity 51292012 Fluoxetine hydrochloride Commodity 51292013 Fluvoxamine Commodity 51292014 Medifoxamine Commodity 51292015 Nisoxetine Commodity 51292016 Sertraline Commodity 51292017 Talopram Commodity 51292018 Tranylcypromine You are here 51292019 Citalopram hydrobromide Commodity 51292020 Citalopram hydrochloride Commodity 51292021 Dapoxetine hydrochloride Commodity 51292022 Diisopromine hydrochloride Commodity 51292023 Escitalopram oxalate Commodity 51292024 Fluvoxamine maleate Commodity 51292025 Medifoxamine fumarate Commodity 51292026 Melitracen hydrochloride Commodity 51292027 Sertraline hydrochloride Commodity 51292028 Talopram hydrochloride Commodity 51292029 Tranylcypromine sulfate Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51290000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class

Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.